glp-1 vs tirzepatide Semaglutide: What You Need to Know GLP-1 Vs Tirzepatide: Powerful Guide

On April 30, 2026, the FDA said they want to ban semaglutide, tirzepatide, and liraglutide from the 503B Bulks List altogether

Since a 1961 report by Paul O'Hollaren, MD, of Shadel Hospital in Seattle, Washington, NAD+ IV infusion has been widely utilized for the treatment of addiction (18-20)

The world of peptide research is moving incredibly fast

These include sarcoidosis, high phosphate blood levels, high calcium blood levels, excessive vitamin D levels, arteriosclerosis with occlusion of the arteries, kidney stones, kidney disease with reduced kidney function, and allergies to vitamin D

Uncontrolled diabetes can result in high levels of sugar in the blood